Fig. 4From: A novel nanobody as therapeutics target for EGFR-positive colorectal cancer therapy: exploring the effects of the nanobody on SW480 cells using proteomics approachComparison of the relative abundance of proteins according to gene ontology terms. Gene ontology categories of biological process (A) and cellular component (B) GO-domain were used for annotation of the identified proteins. The bars represent the relative abundance of GO categoriesBack to article page